Search

Author/Creator Zhu, Viola W

1. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study. Issue 8 (August 2021)

Authors:
Subbiah, Vivek; Hu, Mimi I; Wirth, Lori J; Schuler, Martin; Mansfield, Aaron S; Curigliano, Giuseppe; Brose, Marcia S; Zhu, Viola W; Leboulleux, Sophie; Bowles, Daniel W; Baik, Christina S; Adkins, Douglas; Keam, Bhumsuk; Matos, Ignacio; Garralda, Elena; Gainor, Justin F; Lopes, Gilberto; Lin, Ch...
Journal:
Lancet
Issue:
Volume 9:Issue 8(2021)
Page Start:
491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study. Issue 7 (July 2021)

Authors:
Gainor, Justin F; Curigliano, Giuseppe; Kim, Dong-Wan; Lee, Dae Ho; Besse, Benjamin; Baik, Christina S; Doebele, Robert C; Cassier, Philippe A; Lopes, Gilberto; Tan, Daniel S W; Garralda, Elena; Paz-Ares, Luis G; Cho, Byoung Chul; Gadgeel, Shirish M; Thomas, Michael; Liu, Stephen V; Taylor, Matth...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
959
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search